Perrigo Company plc (PRGO) Insider Trading

Last 12 months

Insiders bought $106k on the open market and sold nothing.

Net open-market

+$106k

1 buy · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

1 / 0

executives and directors

Last open-market buy

Nov 2025

Nov 12, 2025

Get an email when PRGO's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Nov 12, 2025	Geoffrey M. Parker Director	Bought	7,500	$14.18	$106k	12%	Form 4
Sep 8, 2025	Abigail Lennox EVP and CSO	Bought	1,255	$22.41	$28k	New	Form 4
Sep 5, 2025	Charles Atkinson EVP, General Counsel & Sec.	Bought	1,000	$23.20	$23k	New	Form 4
Aug 22, 2025	Robert Willis EVP & CHRO	Bought	1,488	$24.10	$36k	3.7%	Form 4
Aug 18, 2025	Geoffrey M. Parker Director	Bought	4,375	$22.97	$100k	7.3%	Form 4
Aug 18, 2025	Eduardo Guarita Bezerra EVP & Chief Financial Officer	Bought	3,000	$22.74	$68k	6.5%	Form 4
Aug 8, 2025	Patrick Lockwood-Taylor CEO	Bought 3 parts	4,460	$22.37 average	$100k	5.5%	Form 4
May 12, 2025	Geoffrey M. Parker Director	Bought	3,500	$27.10	$95k	6.8%	Form 4
Mar 10, 2025	Ronald Craig Janish EVP, Gbl Ops & SC & CTO	SoldNo plan	7,800	$27.44	$214k	19%	Form 4
Dec 9, 2024	Jeffrey B Kindler Director	Sold10b5-1 plan	17,598	$28.27	$497k	76%	Form 4

Nov 12, 2025
Geoffrey M. Parker
Director · bought 7,500 at $14.18
$106k
12% of stake
Sep 8, 2025
Abigail Lennox
EVP and CSO · bought 1,255 at $22.41
$28k
New position
Sep 5, 2025
Charles Atkinson
EVP, General Counsel & Sec. · bought 1,000 at $23.20
$23k
New position
Aug 22, 2025
Robert Willis
EVP & CHRO · bought 1,488 at $24.10
$36k
3.7% of stake
Aug 18, 2025
Geoffrey M. Parker
Director · bought 4,375 at $22.97
$100k
7.3% of stake
Aug 18, 2025
Eduardo Guarita Bezerra
EVP & Chief Financial Officer · bought 3,000 at $22.74
$68k
6.5% of stake
Aug 8, 2025
Patrick Lockwood-Taylor
CEO · bought 4,460 at avg $22.37
$100k
5.5% of stake
May 12, 2025
Geoffrey M. Parker
Director · bought 3,500 at $27.10
$95k
6.8% of stake
Mar 10, 2025No plan
Ronald Craig Janish
EVP, Gbl Ops & SC & CTO · sold 7,800 at $27.44
$214k
19% of stake
Dec 9, 202410b5-1 plan
Jeffrey B Kindler
Director · sold 17,598 at $28.27
$497k
76% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PRGO, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Pharmaceutical Preparations

ALNYAlnylam Pharmaceuticals Inc

JAZZJazz Pharmaceuticals plc

ELANElanco Animal Health Incorporated

BMRNBiomarin Pharmaceutical Inc.

UTHRUnited Therapeutics Corporation

AMRXAmneal Pharmaceuticals Inc.

RPRXRoyalty Pharma plc

OGNOrganon & Co.

Spot a number that looks wrong? Check it in PRGO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing PRGO

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.